[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Page 36694]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-15555]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated March 16, 2010, and published in the Federal 
Register on March 24, 2010 (75 FR 14187), Meridian Medical 
Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Morphine (9300), a basic class of 
controlled substance listed in schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world, including in Europe. The company has been asked to ensure that 
its product sold to European customers meets standards established by 
the European Pharmacopeia, which is administered by the Directorate for 
the Quality of Medicines (EDQM). In order to ensure that its product 
will meet European specifications, the company seeks to import morphine 
supplied by EDQM to use as reference standards. This is the sole 
purpose for which the company will be authorized by DEA to import 
morphine.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Meridian Medical Technologies to import the basic 
classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Meridian Medical Technologies to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and Sec.  958(a), and 
in accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-15555 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P